Viewing Study NCT00015951


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-26 @ 4:49 PM
Study NCT ID: NCT00015951
Status: COMPLETED
Last Update Posted: 2019-10-17
First Post: 2001-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
Sponsor: University of Maryland, Baltimore
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module